Everest Organics Ltd

Everest Organics Ltd

$EVERESTOPharmaceuticalsBSE

Everest Organics Ltd (EVERESTO) last traded at ₹290, a market capitalisation of ₹289 crore, on a P/E of 55.0. Over the past 52 weeks the stock has ranged between ₹197 and ₹536. Everest Organics Ltd last reported results for the quarter ended Jun 2026, with sales of ₹48.43 crore and net profit of ₹1.11 crore. Everest Organics Ltd’s annual general meeting is scheduled for 30 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.

Everest Organics Ltd share price and key metrics

Current price
₹290
Market cap
₹289 cr
Stock P/E
55.0
Book value
₹77.7
ROE
7.63%
ROCE
12.0%
Dividend yield
0.00%
52w high / low
536/197

Metrics as of 25 Aug 2026. Not real time.

Everest Organics Ltd quarterly results

In the quarter ended Jun 2026, sales were ₹48.43 cr, down 10.0% from ₹53.81 cr a year earlier. Net profit was ₹1.11 cr, down 21.3% year on year.

Everest Organics Ltd consolidated quarterly results, figures in ₹ crore
₹ croreSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales44.0542.0540.9353.815142.5948.7548.43
Expenses40.6238.0337.4949.3745.8739.0542.0544.1
Operating profit3.434.023.444.445.133.546.74.33
OPM %7.79%9.56%8.40%8.25%10.06%8.31%13.74%8.94%
Other income0.1400.220.550.290.250.160.42
Interest1.351.41.151.311.231.232.761.63
Depreciation1.471.471.561.521.521.521.931.59
Profit before tax0.751.150.952.162.671.042.171.53
Tax %1.33%0.87%-206.32%35.19%56.93%65.38%-21.20%26.80%
Net profit0.741.142.911.411.160.362.631.11
EPS (₹)0.921.423.001.451.190.372.711.14

Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.

Everest Organics Ltd annual results

Everest Organics Ltd annual profit and loss, figures in ₹ crore
₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales182200183197159196191
Operating profit23611172020
OPM %13%3.2%0.5%6%4.5%10%10%
Net profit141-00-165
EPS (₹)17.151.42-0.220.18-1.335.725.41

TTM is the trailing twelve months to the most recent quarter.

Everest Organics Ltd growth and returns

Compounded Sales Growth
10 Years
7%
5 Years
2%
3 Years
2%
TTM
5%
Compounded Profit Growth
10 Years
21%
5 Years
-17%
3 Years
315%
TTM
-15%
Stock Price CAGR
10 Years
20%
5 Years
1%
3 Years
37%
1 Year
-28%
Return on Equity
10 Years
10%
5 Years
2%
3 Years
2%
Last Year
8%

Everest Organics Ltd shareholding pattern

Promoters held 59.60% at Jun 2026, down from 60.99% at Jun 2025. DIIs 0.02%.

Everest Organics Ltd shareholding pattern by quarter, in percent
% heldSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters74.15%74.15%61.09%60.99%59.64%59.61%59.58%59.60%
DIIs0.05%0.05%0.02%0.02%0.02%0.02%0.02%0.02%
Public25.81%25.80%38.90%38.99%40.35%40.36%40.40%40.38%
No. of shareholders9,9969,3268,7568,2818,0797,8047,8807,827

As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.

When is Everest Organics Ltd’s AGM?

Everest Organics Ltd’s annual general meeting is scheduled for 30 Sept 2026.

  • AGM33rd Annual General Meeting

See the full results calendar for every Indian company reporting in the next 30 days.

Everest Organics Ltd corporate filings

  • News Paper publications of Un-audited Financial Results for the Quarter ended June 30, 2026Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Everest Organics Limited has formally published its unaudited standalone financial…

    Read the full analysis
  • EnclosedCorp. Actionlow impact
    Filing PDF

    Cruxal's analysis: Everest Organics Ltd has announced the cut-off date for determining the eligibility of…

    Read the full analysis
  • EnclosedCorp. Actionlow impact
    Filing PDF

    Cruxal's analysis: Everest Organics Ltd has fixed the book closure dates for its 33rd Annual General…

    Read the full analysis
  • EnclosedBoard Meetingmedium impact
    Filing PDF

    Cruxal's analysis: Everest Organics Limited has announced the appointment of Mr. Srikanth Reddy Kolli and…

    Read the full analysis
  • EnclosedResulthigh impact
    Filing PDF

    Cruxal's analysis: Everest Organics Limited reported Q1 FY27 revenue of 48.43 crore, a decline from 53.81…

    Read the full analysis
  • Everest Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Board Meeting is scheduled ....Board Meetinglow impact
    Filing PDF

    Cruxal's analysis: Everest Organics Limited has issued a formal intimation regarding a Board Meeting…

    Read the full analysis

This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.

Track Everest Organics Ltd

Cruxal reads every Everest Organics Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Cruxal publishes market data and coverage for information only. Nothing here is investment advice.

Everest Organics Ltd (EVERESTO) Results, Financials & Share Price | Cruxal